跳至主要内容
临床试验/NCT06594718
NCT06594718尚未招募不适用

Endoscopic Treatment of Zenker's Diverticulum: a Prospective Observational Study Comparing Tunnelization (Z-POEM) Versus Non-Tunnelization Techniques

Société Française d'Endoscopie Digestive0 个研究点目标入组 128 人开始时间: 2024年10月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
128
主要终点
Symptomatic recurrence rate after endoscopic tunnelization therapy (Z-POEM) compared to non-tunnelization techniques in patients with symptomatic Zenker's diverticulum.

研究概览

简要总结

Prospective comparative observational study in numerous reference centers in France, comparing Tunnelization (Z-POEM) versus Non-Tunnelization Techniques according to the usual practices. This is a prospective, comparative, observational, multicenter study with the primary objective of comparing the symptomatic recurrence rate one year after endoscopic tunnelization therapy (Z-POEM) versus non-tunnelization techniques in patients with symptomatic Zenker's diverticulum.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic Zenker's diverticulum (Augsburg score ≥5 )
  • Diagnostic evaluation including esophagogastroduodenoscopy (EGD) and a barium swallow (TOGD) with measurement of the diverticulum's height.
  • Patient aged 18 years or older
  • Patient with ASA 1, ASA 2, ASA 3 status
  • No participation in another concurrent clinical study

排除标准

  • Patient under 18 years old
  • Patient with ASA 4 or ASA 5 status
  • Pregnant woman
  • Patient with coagulation disorders preventing the performance a polypectomy: PT < 50%, Platelets < 50,000/mm³, ongoing effective anticoagulation, or current clopidogrel use.
  • Patient who has already undergone initial endoscopic or surgical treatment for Zenker's diverticulum

结局指标

主要结局

Symptomatic recurrence rate after endoscopic tunnelization therapy (Z-POEM) compared to non-tunnelization techniques in patients with symptomatic Zenker's diverticulum.

时间窗: 12 months

Symptomatic recurrence is defined by: Clinical resolution after endoscopic treatment, as assessed clinically at 3 months, with an Augsburg score \<5. Reappearance of clinical symptoms, following clinical resolution after endoscopic treatment, with an Augsburg score ≥5.

次要结局

  • Complication rate associated with the endoscopic procedure(15 days)
  • Clinical success rate after endoscopic treatment.(3 months)
  • Variation in Augsburg score at different time points(3 months, 6 months, 12 months, and 24 months)
  • Radiographic resolution rate of the diverticulum(3 months)
  • Symptomatic Recurrence Rate Post-Treatment:(at 3, 6, 12, and 24 Months)

研究者

发起方
Société Française d'Endoscopie Digestive
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bertrand Brieau

Medical doctor, Principal Investigator

Société Française d'Endoscopie Digestive

相似试验

Endoscopic Treatment of Zenker's Diverticulum... | 临床试验